AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Director's Dealing 2014

Jan 29, 2014

Director's Dealing

Opens in your device viewer

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP.OB)
CIK: 0001176309
Period of Report: 2012-08-08

Reporting Person: JACOB HAROLD (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-08	Stock Option (right to buy)	$0.34	A	240000	Acquired	2012-08-08	Common Stock (240000)	Direct

F1: 120,000 shares will vest on each of January 1, 2013 and January 1, 2014.